Label: K2LTS TELOMERASE INHIBITOR- telomerase inhibitor liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated June 20, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    ginsenoside 23%

  • Purpose

    Indications: This drug is indicated for cancer patients, people with a family history of cancer, or people exposed to work with radioactivity.

  • Use

    Product Benefits: This product can inhibit the activity of telomerase, thus preventing the proliferation and growth of tumor cells;

  • Warnings

    This product should not be used in combination with antibiotics;

  • Do not use

    This product should not be used in patients who are allergic to any component of this product;

  • When Using

    Precautions: Combined use with other drugs or increased exposure to this product may result in clinically significant adverse reactions. Combined use with other drugs may significantly decrease the concentration of this product, leading to decreased therapeutic effect of the drug combination.

  • Stop Use

    If there is any discomfort during use, please discontinue this product.

  • Ask Doctor

    If the patient has any underlying medical condition, please consult the doctor before taking this product.

  • Keep Oot Of Reach Of Children

    Please keep this product away from children. If the child accidentally ingests this product, please seek medical help immediately.

  • Directions

    Usage: Twist off the bottle cap and take it directly; Take it twice a day; Do not overdose.

  • Other information

    Storage: This product should be stored in a cool, dry, dark place with the temperature of 16℃-27℃ and the humidity ≤ 50%.

  • Inactive ingredients

    EGCG Sulforaphane cordycepin Ergothioneine Selenium Sodium benzoate

  • PRINCIPAL DISPLAY PANEL

    1

  • INGREDIENTS AND APPEARANCE
    K2LTS TELOMERASE INHIBITOR 
    telomerase inhibitor liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84429-002
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    GINSENOSIDES (UNII: 3K198YD54P) (GINSENOSIDES - UNII:3K198YD54P) GINSENOSIDES23 g  in 100 
    Inactive Ingredients
    Ingredient NameStrength
    SELENIUM (UNII: H6241UJ22B)  
    CORDYCEPIN (UNII: GZ8VF4M2J8)  
    SULFORAPHANE (UNII: GA49J4310U)  
    ERGOTHIONEINE (UNII: BDZ3DQM98W)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    EPIGALLOCATECHIN GALLATE (UNII: BQM438CTEL)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:84429-002-0120 in 1 BOX; Type 0: Not a Combination Product06/20/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other06/20/2024
    Labeler - K2LT LAB, LLC (072189878)
    Establishment
    NameAddressID/FEIBusiness Operations
    K2LT LAB, LLC072189878manufacture(84429-002)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!